Learning Objectives

At the end of this CME/CE activity, participants should be able to:

• Describe the natural progression of chronic kidney disease (CKD) in an environment of hypertension, diabetes and the metabolic syndrome.
• Identify current and future clinical trials exploring the link between CKD, hypertension and diabetes.
• Examine intervention strategies utilizing combination therapy in the hypertension, CKD and diabetes environment.
• Describe the role of microalbuminuria and proteinuria as they relate to CKD staging.
• Discuss the definition of the metabolic syndrome vs. metabolic risk.